APA

Seitz C., Bumbuliene Ž., Costa A. R., Heikinheimo O., Heweker A., Hudeček R., Jacquemyn Y., Melis G. B., Parashar P., Rechberger T., Sánchez A. C., van Aken B., Zatik J. & Gemzell-Danielsson K. (20171204). Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids. : Contemporary clinical trials.

Chicago

Seitz Christian, Bumbuliene Žana, Costa Ana Rosa, Heikinheimo Oskari, Heweker Andrea, Hudeček Robert, Jacquemyn Yves, Melis Gian Benedetto, Parashar Pooja, Rechberger Tomasz, Sánchez Antonio Cano, van Aken Bart, Zatik János and Gemzell-Danielsson Kristina. 20171204. Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids. : Contemporary clinical trials.

Harvard

Seitz C., Bumbuliene Ž., Costa A. R., Heikinheimo O., Heweker A., Hudeček R., Jacquemyn Y., Melis G. B., Parashar P., Rechberger T., Sánchez A. C., van Aken B., Zatik J. and Gemzell-Danielsson K. (20171204). Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids. : Contemporary clinical trials.

MLA

Seitz Christian, Bumbuliene Žana, Costa Ana Rosa, Heikinheimo Oskari, Heweker Andrea, Hudeček Robert, Jacquemyn Yves, Melis Gian Benedetto, Parashar Pooja, Rechberger Tomasz, Sánchez Antonio Cano, van Aken Bart, Zatik János and Gemzell-Danielsson Kristina. Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids. : Contemporary clinical trials. 20171204.